Abstract
The basic features of bronchial asthma are dyspnea with wheezing and objectively confirmed obstructive respiratory disorder reversible after inhalation of bronchodilators. In stable intermittent bronchial asthma, these features are not present; therefore confirmation of asthma consists of the presence of bronchial hyperresponsiveness (BHR). In the present study, there were 902 bronchoprovocation tests performed for the verification of BHR. A significant criterium for BHR is a decrease of FEV1 of 20% from the baseline level. Every test either positive or negative was finished with inhalation of four doses of salbutamol through a spacer. We obtained 675 bronchoprovocation tests negative and 227 positive. Among the 675 subjects with a negative test there were 49 subjects who after inhalation of salbutamol had an increase in FEV1 of ≥20% above baseline. The bronchodilatatory response of these 49 subjects, makes one think about the so-called latent bronchospasm present already at baseline, limiting further constriction during bronchoprovocation tests. The detection of such latent bronchospasm in BHR increases the number of patients with an objectively confirmed bronchial asthma from 25.0% to 30.5%. Our results suggest that bronchodilation test be performed in all patients with suspected bronchial asthma to allow detecting latent bronchospasm as an initial stage of the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AARC Clinical Practice Guideline. (2001). Methacholine challenge testing: 2001 revision & update. Respiratory Care, 46, 523–530.
American Thoracic Society. (2000). Guidelines for methacholine and exercise challenge testing-1999: Official statement of the American Thoracic Society. American Journal of Respiratory and Critical Care Medicine, 161, 309–329.
Grootendorst, D. C., & Rabe, K. F. (2004). Mechanism of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society, 1, 77–87.
Joos, G. F., O’Connor, B., Anderson, S. D., Chung, F., Cockcroft, D. W., Dahlen, B., DiMaria, G., Foresi, A., Hargreave, F. E., Holgate, S. T., Inman, M., Lötvall, J., Magnussen, H., Polosa, R., Postma, D. S., Riedler, J. E. R. S., & Force, T. (2003). Indirect airway challenges. European Respiratory Journal, 21, 1050–1068.
NHLBI/WHO. (2010). Workshop report: Global strategy for asthma management and prevention, updated 2010. www.ginasthma.org. Accessed 20 May 2012.
Sterk, P. J., Fabbri, L. M., Quanjer, P., Cockcroft, D. W., O’Byrne, P. M., Anderson, S. D., Juniper, E. F., & Malo, J. L. (1993). Airway responsiveness: Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. European Respiratory Journal, 6(Suppl. 16), 53–83.
Trigg, C. J., Manolitsas, N. D., Wang, J., Calderón, M. A., McAulay, A., Jordan, S. E., Herdman, M. J., Jhalli, N., Duddle, J. M., & Hamilton, S. A., et al. (1994). Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. American Journal of Respiratory and Critical Care Medicine, 150, 17–22.
Acknowledgements
Supported by Ministry of Education Slovak Republic Grant VEGA 1/1065/11.
Conflicts of Interest: The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Legath, L., Perecinsky, S., Varga, M., Orolin, M., Tomori, Z., Legath, J. (2013). Latent Airway Hyperresponsiveness: A Phenomenon Bordering Bronchial Asthma Definition. In: Pokorski, M. (eds) Respiratory Regulation - Clinical Advances. Advances in Experimental Medicine and Biology, vol 755. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4546-9_13
Download citation
DOI: https://doi.org/10.1007/978-94-007-4546-9_13
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4545-2
Online ISBN: 978-94-007-4546-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)